APOLIPOPROTEIN E IN NEUROBIOLOGY: CELLULAR MECHANISMS
神经生物学中的载脂蛋白 E:细胞机制
基本信息
- 批准号:7431632
- 负责人:
- 金额:$ 31.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:3-hydroxy-3-methylglutaryl-coenzyme A6-carboxyfluoresceinAbbreviationsAbeta clearanceAffectAge of OnsetAllelesAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorApolipoprotein EApolipoproteinsArginineBindingBiologyBrainCaliforniaCell DeathCell membraneCell physiologyCellsCellular MembraneCellular NeurobiologyCerebrospinal FluidCharacteristicsChemosensitizationCholesterolCoenzyme AComplexConditionCyclin-Dependent Kinase 5CysteineCytoskeletonDataDepositionDevelopmentDimyristoylphosphatidylcholineDiseaseDisruptionEaglesEdetic AcidEnzyme-Linked Immunosorbent AssayExtracellular Signal Regulated KinasesExtravasationFigs - dietaryFluoresceinFluorescein-5-isothiocyanateFluoresceinsGenerationsGlutamic AcidGlycogen Synthase Kinase 3GoalsHeparan Sulfate ProteoglycanHigh Density LipoproteinsHumanIn VitroInclusion BodiesInorganic SulfatesInstitutesIntracellular MembranesIsothiocyanatesLDL-Receptor Related Protein 1LeadLightLinkLow-Density LipoproteinsLysosomesMediatingMembraneMembrane LipidsMicrotubulesMitogen-Activated Protein KinasesMolecularMolecular WeightMusNervous system structureNeuraxisNeurobiologyNeurodegenerative DisordersNeurofibrillary TanglesNeuron-Specific EnolaseNeuronsPathogenesisPathway interactionsPhosphate BufferPhysiologicalPilot ProjectsPlayPolyacrylamide Gel ElectrophoresisPredispositionProcessProductionPropertyProtease InhibitorProtein IsoformsProtein OverexpressionProteinsRNA InterferenceRecyclingResearch PersonnelRisk FactorsRoleSalineSan FranciscoSecondary toSodiumStructureSusceptibility GeneTransgenic MiceTransgenic OrganismsUniversitiesUnspecified or Sulfate Ion SulfatesVery low density lipoproteinage relatedapolipoprotein E-3apolipoprotein E-4basein vivoinsightmutantneurofibrillary tangle formationneurofilamentneuropathologynovel therapeuticspeptide Apreventprogramsreceptorrepairedtau Proteinstau aggregationtau phosphorylationtau-1therapeutic target
项目摘要
Apolipoprotein (apo) E4 has been identified as a major risk factor or susceptibility gene for the development of Alzheimer's disease and other neurodegenerative disorders. Several hypotheses have been advanced to explain this association, including its role in altering amyloid beta (Abeta) peptide clearance and/or deposition (plaque formation), altering tau phosphorylation and microtubule biology (tangle formation), and altering cytoskeletal structure and function (remodeling and repair). Thus, apoE3 and apoE4 may impact neurobiology and neuropathology through multiple processes or pathways. In fact, it is reasonable to speculate that under various physiological or pathological conditions apoE may play different roles, some of which undoubtedly remain to be elucidated. Recent preliminary studies have extended our understanding of isoform-specific effects of apoE on neurons and may shed light on additional unique roles for apoE in neurobiology. First, apoE4 stimulates Abeta production in neuronal cells to a greater extent than apoE3 and the enhanced Abeta production is associated with increased amyloid precursor protein recycling. Sccond, apoE4 potentiates Abeta-induced lysosomal leakage and cell death whereas apoE3 does not. Third, apoE4 undergoes proteolytic cleavage to form intracellular carboxyl-terminal-truncated forms of apoE that induce neurofibrillary tangle-like inclusion formation in neurons (apoE4 > apoE3). Transgenic apoE4 mice expressing apoE in neurons have increased levels of tangle-like structures and phosphorylated tau inclusion bodies in neurons. The goal of this project is to investigate the mechanisms whereby apoE3 versus apoE4 alters these cellular pathways, including the apoE isoform-specific effects on Abeta production (Aim 1), Abeta-induced lysosomal leakage (Aim 2), and the formation of neurofibrillary tangle-like inclusions in neurons associated with the generation of bioactive intracellular proteolytic fragments of apoE (Aim 3). We will determine how these cellular pathways are
modulated by the unique structural (conformational) characteristics of apoE, including domain interaction, in which the amino- and carboxyl-terminal domains interact only in apoE4 (arginine-61 reacting with glutamic acid-255) and molecular instability, in which apoE4 more readily forms reactive folding intermediates than apoE3. These studies, involving both in vitro and in vivo approaches, will provide additional insights into the role of apoE4 and may identify new therapeutic targets for apoE4-associated neuropathological disorders.
载脂蛋白(apo)E4已被确定为阿尔茨海默病和其他神经退行性疾病发展的主要危险因素或易感基因。已经提出了几种假说来解释这种关联,包括其在改变淀粉样蛋白β(Abeta)肽清除和/或沉积(斑块形成),改变tau磷酸化和微管生物学(缠结形成)以及改变细胞骨架结构和功能(重塑和修复)中的作用。因此,apoE 3和apoE 4可能通过多种过程或途径影响神经生物学和神经病理学。事实上,推测apoE在不同的生理或病理条件下可能发挥不同的作用是合理的,其中一些无疑仍有待阐明。最近的初步研究扩展了我们对apoE对神经元的亚型特异性作用的理解,并可能揭示apoE在神经生物学中的其他独特作用。首先,apoE 4比apoE 3更大程度地刺激神经元细胞中的Abeta产生,并且增强的Abeta产生与增加的淀粉样前体蛋白再循环有关。第二,apoE 4增强A β诱导的溶酶体渗漏和细胞死亡,而apoE 3不增强。第三,apoE 4经历蛋白水解切割以形成细胞内羧基末端截短形式的apoE,其诱导神经元缠结样包涵体在神经元中形成(apoE 4> apoE 3)。在神经元中表达apoE的转基因apoE 4小鼠神经元中缠结样结构和磷酸化tau包涵体的水平增加。本项目的目的是研究apoE 3与apoE 4改变这些细胞通路的机制,包括apoE亚型对Abeta产生的特异性作用(Aim 1),Abeta诱导的溶酶体渗漏(Aim 2),以及与apoE生物活性细胞内蛋白水解片段产生相关的神经元缠结样包涵体的形成(Aim 3)。我们将确定这些细胞通路是如何
受apoE的独特结构(构象)特征调节,包括结构域相互作用,其中氨基和羧基末端结构域仅在apoE 4中相互作用(精氨酸-61与谷氨酸-255反应)和分子不稳定性,其中apoE 4比apoE 3更容易形成反应性折叠中间体。这些研究,涉及在体外和体内的方法,将提供更多的见解apoE 4的作用,并可能确定新的治疗靶点apoE 4相关的神经病理性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT W. MAHLEY其他文献
ROBERT W. MAHLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT W. MAHLEY', 18)}}的其他基金
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4
生长抑素 (SST)-GABA 能中间神经元治疗 ApoE4 治疗阿尔茨海默病
- 批准号:
9893103 - 财政年份:2019
- 资助金额:
$ 31.52万 - 项目类别:
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease
开发 GABA 能神经元保护剂来治疗 ApoE4 相关的阿尔茨海默病
- 批准号:
10056515 - 财政年份:2019
- 资助金额:
$ 31.52万 - 项目类别:
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4
生长抑素 (SST)-GABA 能中间神经元治疗 ApoE4 治疗阿尔茨海默病
- 批准号:
10011752 - 财政年份:2019
- 资助金额:
$ 31.52万 - 项目类别:
ApoE4 Structure Correctors as a Therapeutic Approach for Alzheimers Disease
ApoE4 结构校正剂作为阿尔茨海默病的治疗方法
- 批准号:
8460847 - 财政年份:2012
- 资助金额:
$ 31.52万 - 项目类别:
Targeting ApoE4 as a Therapeutic Strategy for Alzheimer's Disease
以 ApoE4 为靶点作为阿尔茨海默病的治疗策略
- 批准号:
8549072 - 财政年份:2012
- 资助金额:
$ 31.52万 - 项目类别:
ApoE4 Structure Correctors as a Therapeutic Approach for Alzheimers Disease
ApoE4 结构校正剂作为阿尔茨海默病的治疗方法
- 批准号:
8328029 - 财政年份:2012
- 资助金额:
$ 31.52万 - 项目类别:
Targeting ApoE4 as a Therapeutic Strategy for Alzheimer's Disease
以 ApoE4 为靶点作为阿尔茨海默病的治疗策略
- 批准号:
8420245 - 财政年份:2012
- 资助金额:
$ 31.52万 - 项目类别:
Role of apoE structure and metabolism in neurodegeneration
apoE结构和代谢在神经退行性变中的作用
- 批准号:
8235856 - 财政年份:2008
- 资助金额:
$ 31.52万 - 项目类别:
Role of apoE structure and metabolism in neurodegeneration
apoE结构和代谢在神经退行性变中的作用
- 批准号:
8036997 - 财政年份:2008
- 资助金额:
$ 31.52万 - 项目类别:
Targeting Apolipoprotein E4-related Neuropathology
靶向载脂蛋白 E4 相关神经病理学
- 批准号:
6752398 - 财政年份:2003
- 资助金额:
$ 31.52万 - 项目类别: